Elevance Health, Inc.
ELVNYSE · SIC 6324
$373.11
↑ +0.1%Jul 17 close · end-of-day
Price
1Y↑ +10.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$81.3B
Enterprise Value
$76.4B
P/E
16.5
P/S
0.4
P/B
1.8
EV/EBITDA
11.0
PEG
13.1
FCF Yield
7.7%
Dividend Yield
1.8%
Revenue (TTM)
$201.1B
Net Income (TTM)
$5.0B
Free Cash Flow (TTM)
$6.3B
Gross Margin
—
Operating Margin
2.7%
Net Margin
2.5%
ROE
11.1%
ROIC
11.5%
Debt / Equity
0.7
Net Cash
$4.9B
Return 1Y
+25.9%
Company profile
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
- CEO
- Gail K. Boudreaux
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Insurance
- Employees
- 102,300
- Headquarters
- Indiana
- Website
- elevancehealth.com
Management & directors
- Boudreaux GailPresident and CEO
- Penczek Ronald WCAO & Controller
- Kendrick Charles Morgan JrEVP & President, Commercial
- Craig Ryan REVP & Chief HR Officer
- Haytaian Peter DEVP & Pres Carelon & CarelonRx
- Kaye MarkEVP & CFO
- Lavu RatnakarEVP & Chief Digital Info Ofr
- Norwood Felicia FEVP &Chief Health Benefits Ofr
- Wessling Erin MEVP & Chief Legal Officer
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-10-14
ELV Q2 2026 Earnings
Period ends 2026-06-30
MetricActualYoY
Revenue$50.5B↑ +1.4%
Diluted EPS$6.71↓ -13.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $121.9B | $138.6B | $156.6B | $171.3B | $177.0B | $199.1B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $6.4B | $7.6B | $8.3B | $8.5B | $7.9B | $7.2B |
| Net income | $4.6B | $6.2B | $5.9B | $6.0B | $6.0B | $5.7B |
| Diluted EPS | $17.98 | $24.95 | $24.28 | $25.22 | $25.68 | $25.21 |
| Operating cash flow | $10.7B | $8.4B | $8.4B | $8.1B | $5.8B | $4.3B |
| Free cash flow | $9.7B | $7.3B | $7.2B | $6.8B | $4.6B | $3.2B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 5.2% | 5.5% | 5.3% | 5.0% | 4.4% | 3.6% |
| Net margin | 3.8% | 4.4% | 3.8% | 3.5% | 3.4% | 2.8% |
| Line item | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $45.1B | $45.4B | $48.9B | $49.8B | $50.7B | $49.7B | $50.2B | $50.5B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.4B | $673.0M | $3.2B | $2.4B | $1.3B | $309.0M | $2.1B | $1.8B |
| Net income | $1.0B | $418.0M | $2.2B | $1.7B | $1.2B | $547.0M | $1.8B | $1.5B |
| Diluted EPS | $4.36 | $1.88 | $9.61 | $7.72 | $5.32 | $2.56 | $8.00 | $6.71 |
| Operating cash flow | $2.7B | $706.0M | $1.0B | $2.1B | $1.1B | $84.0M | $4.3B | $1.9B |
| Free cash flow | $2.3B | $384.0M | $821.0M | $1.8B | $775.0M | -$209.0M | $4.1B | $1.6B |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 3.1% | 1.5% | 6.5% | 4.9% | 2.6% | 0.6% | 4.2% | 3.5% |
| Net margin | 2.3% | 0.9% | 4.5% | 3.5% | 2.3% | 1.1% | 3.5% | 2.9% |
Company news
Jul 20, 2026
Jul 18, 2026
Jul 17, 2026
- 2d agoElevance Health CEO Snaps Up Stock After Post-Earnings Slidefinance.yahoo.com
- 2d agoWhat A Patient Holder Is Really Paying For CVS Health Stocktrefis.com
- 2d agoWhat's A Strong Quarter Worth When Elevance Health Is Ditching Its Own Markets?trefis.com
- 3d agoElevance Health CEO Boudreaux Buys $1 Million in Shares. What Does This Mean For its 2026 Outlook?fool.com
Jul 16, 2026
- 4d agoWhy UNH Stock Breakout Faltered After Massive Earnings Beatfinance.yahoo.com
- 4d agoUnitedHealth stock jumps on Q2 earnings, raises full-year outlookfinance.yahoo.com
- 4d agoElevance Health (ELV) Stock Sees Modest Fair Value Lift As Analysts Turn More Constructivefinance.yahoo.com
- 4d agoThe Medicaid Problem That Swallowed an Earnings Beattrefis.com
- 4d agoThe Medicaid Problem Weighing On Elevance Health Stocktrefis.com
- 4d agoThe Real Price of Admission for CVS Health Stocktrefis.com
- 4d agoUNH Stock Flashes Buy Signal On Massive Earnings Beatfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-17 | BOUDREAUX GAIL· President and CEO | Buy | 2,045 | $368.25 | $753,071.25 | filing |
| 2026-07-17 | PERU RAMIRO G | Buy | 1,000 | $366.05 | $366,050.00 | filing |
| 2026-07-17 | BOUDREAUX GAIL· President and CEO | Buy | 680 | $366.41 | $249,158.80 | filing |
| 2026-06-12 | Penczek Ronald W· CAO & Controller | Sale | 369 | $403.16 | $148,766.04 | filing |
| 2026-06-11 | Dixon Robert L JR | Sale | 151 | $401.77 | $60,667.27 | filing |
| 2026-05-19 | Penczek Ronald W· CAO & Controller | Sale | 1,531 | $403.13 | $617,192.03 | filing |
| 2026-05-19 | Penczek Ronald W· CAO & Controller | Option exercise | 877 | $311.48 | $273,167.96 | filing |
| 2026-05-19 | Penczek Ronald W· CAO & Controller | Option exercise | 654 | $271.27 | $177,410.58 | filing |
| 2026-05-13 | DeVore Susan D. | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | COLLIS STEVEN H | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | Dixon Robert L JR | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | STRABLE-SOETHOUT DEANNA D | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | SCHULMAN AMY W | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | Schneider Ryan M. | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | PERU RAMIRO G | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | Neri Antonio F | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | Jallal Bahija | Award | 563 | $0.00 | $0.00 | filing |
| 2026-05-13 | HAY LEWIS III | Award | 563 | $0.00 | $0.00 | filing |
| 2026-03-12 | SCHULMAN AMY W | Sale | 26 | $287.50 | $7,475.00 | filing |
| 2026-03-06 | Kendrick Charles Morgan JR· EVP & President, Commercial | Sale | 3,196 | $284.92 | $910,604.32 | filing |
| 2026-03-05 | COLLIS STEVEN H | Buy | 3,000 | $289.84 | $869,520.00 | filing |
| 2026-03-03 | BOUDREAUX GAIL· President and CEO | Tax withholding | 1,736 | $284.03 | $493,076.08 | filing |
| 2026-03-03 | Norwood Felicia F· EVP &Chief Health Benefits Ofr | Tax withholding | 496 | $284.03 | $140,878.88 | filing |
| 2026-03-03 | Kendrick Charles Morgan JR· EVP & President, Commercial | Tax withholding | 467 | $284.03 | $132,642.01 | filing |
| 2026-03-03 | Haytaian Peter D· EVP & Pres Carelon & CarelonRx | Tax withholding | 446 | $284.03 | $126,677.38 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.